Overview

Dusquetide for the Treatment of Behcet's Disease

Status:
COMPLETED
Trial end date:
2025-06-17
Target enrollment:
Participant gender:
Summary
This is a clinical study to see if dusquetide can treat flares of oral and genital ulcers caused by Behcet's Disease. Study participants will receive an infusion of dusquetide twice a week for 4 weeks (8 treatments total), with weekly follow-up visits for an additional 4 weeks.
Phase:
PHASE2
Details
Lead Sponsor:
Soligenix
Treatments:
dusquetide